|
Sno.
|
Test Name
|
Min Qty
|
Ref. Value
|
|
1
|
A.S.O. TITRE
|
0.5 ml
|
Adults : upto 200 IU/ml Children : upto 150 IU/ml
|
|
2
|
A/G RATIO
|
|
|
|
3
|
ABDOMEN - ERECT VIEW (XRAY)
|
|
|
|
4
|
ABDOMEN (X -RAY)
|
|
|
|
5
|
ABDOMEN SCAN
|
|
|
|
6
|
ABSOLUTE NEUTROPHIL COUNT
|
1 ml
|
|
|
7
|
ABSOLUTE B CELL COUNT
|
|
|
|
8
|
ABSOLUTE EOSINOPHIL COUNT
|
1 ml
|
100 - 400 cells/cmm
|
|
9
|
ABSOLUTE LYMPHOCYTE COUNT
|
2 ml
|
1550 - 4000 cells/cmm.
|
|
10
|
ABSOLUTE LYMPHOCYTE COUNT
|
1 ml
|
1550 - 4000 cells/cmm.
|
|
11
|
ABSOLUTE NEUTROPHIL COUNT
|
2 ml
|
2500 - 7000 Cells/cmm
|
|
12
|
ACE ( ANGIO TENSIN CONVERTING ENZYME)
|
|
8-52 U/L
|
|
13
|
ACETYL CHOLINE RECEPTOR ANTIBODIES
|
|
Normal Levels : 0.0 to 0.25 nMol/L Borderline Levels : 0.25 to 0.4 nMol/L Positive levels : More than 0.4 nMol/L
|
|
14
|
ACID PHOSPHATASE (PROSTATIC #)
|
1 ml
|
0 - 1.6 U/l
|
|
15
|
ACID PHOSPHATASE (TOTAL)
|
1 ml
|
0 - 4.7 U/l
|
|
16
|
ACTH
|
1 ml
|
7.2 - 63.3 pg/ml
|
|
17
|
ACTH STIMULATED 17 - OHP ( B)
|
|
|
|
18
|
ACTH - PM
|
|
UP TO 46.0 pg/ml.
|
|
19
|
ACTH STIMULATED 17 OHP
|
|
Males : 0.5 - 2.1 ng/ml
Females
Follicular Phase : 0.1 - 0.8 ng/ml Luteal Phase : 0.6 - 2.3 ng/ml Ovulation : 0.3 - 1.4 ng/ml
Pregnancy
3rd Trimester : 2.0 - 12.0 ng/ml
CHILDREN (Girls)
1 month after birth : 2.4 - 16.8 ng/ml 2 month after birth : 1.6 - 9.7 ng/ml 3 month after birth : 0.1 - 3.1 ng/ml
CHILDREN (Boys)
1 month after birth : 0.0 - 8.0 ng/ml 2 month after birth : 3.6 - 13.7 ng/ml 3 month after birth : 1.7 - 4.0 ng/ml
Post ACTH: <3.2 ng/ml
Postmenopausal women: 0.13 - 0.51 ng/ml
|
|
20
|
ACTH STIMULATED CORTISOL
|
|
|
|
21
|
Activated Protein - C Resistance(APC - R)
|
1 ml
|
|
|
22
|
ADENOSINE DEAMINASE (ADA) (ASCITIC FLUID)
|
2 ml
|
Normal : 0-30 U/L
Positive : > 30 U/L
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
|
23
|
ADENOSINE DEAMINASE (ADA) (PERICARDIAL FLUID)
|
2 ML
|
Normal : < 30 U/L Suspect : 30 - 40 Strong suspect : 40 - 60 Positive : > 60
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
|
24
|
ADENOSINE DEAMINASE (ADA)(BRONCHIAL WASH)
|
|
|
|
25
|
ADENOSINE DEAMINASE (ADA)(CSF)
|
|
Normal : < 9 U/L Positive : > 9 U/L
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
|
26
|
ADENOSINE DEAMINASE (ADA)(PERITONEAL FLUID)
|
|
|
|
27
|
ADENOSINE DEAMINASE (ADA)(PLEURAL FLUID)
|
|
Normal : 0-30 U/L
Positive : > 30 U/L
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
|
28
|
ADENOSINE DEAMINASE (ADA)(SERUM)
|
2 mL
|
Normal : 0-15 U/L Positive : > 15 U/L
ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and Malignancy.
|
|
29
|
Advice & Suggestions
|
|
|
|
30
|
AFB STAIN
|
|
|
|
31
|
AFB BACTEC ( MGIT) 460 - ISONIAZID (INH)
|
|
|
|
32
|
AFB BACTEC 460 - AMIKACIN
|
|
|
|
33
|
AFB BACTEC 460 - ETHAMBUTOL
|
|
|
|
34
|
AFB BACTEC 460 (MGIT) - SIREP
|
|
|
|
35
|
AFB BACTEC 460 - CIPROFLOXACIN
|
|
|
|
36
|
AFB BACTEC 460 - CYCLOSERINE
|
|
|
|
37
|
AFB BACTEC 460 - ETHIONAMIDE
|
|
|
|
38
|
AFB BACTEC 460 - KANAMYCIN
|
|
|
|
39
|
AFB BACTEC 460 - OFLOXACIN
|
|
|
|
40
|
AFB BACTEC 460 - PAS
|
|
|
|
41
|
AFB BACTEC 460 - PYRAZINAMIDE
|
|
|
|
42
|
AFB BACTEC 460 - RIFAMPICIN
|
|
|
|
43
|
AFB BACTEC 460 - STREPTOMYCIN
|
|
|
|
44
|
AFB BACTEC 460 -GENTAMICIN
|
|
|
|
45
|
AFB BACTEC 460( MGIT) - SIRE
|
|
|
|
46
|
AFB CULTURE by BACTEC ( MGIT)-Other Specimens
|
|
|
|
47
|
AFB CULTURE BY BACTEC( MGIT) Sputum
|
|
|
|
48
|
AFB STAIN (BRONCHIAL WASH)
|
|
|
|
49
|
AFB STAIN (PERICARDIAL FLUID)
|
|
|
|
50
|
AFB STAIN - CONCENTRATED METHOD
|
|
|
|
51
|
AFP ( ASCITIC FLUID)
|
2 ML
|
|
|
52
|
AFP (ALPHA FETO PROTEINS)
|
1 ML
|
Normal Adults : 0 - 7.0 ng/ml
AFP (MATERNAL SERUM) Cut off 2.5 MoM 14 weeks : upto 27.9 ng/ml 69.75 15 weeks : upto 30.9 ng/ml 77.25 16 weeks : upto 36.1 ng/ml 90.25 17 weeks : upto 40.4 ng/ml 101.0 18 weeks : upto 48.3 ng/ml 120.75 19 weeks : upto 54.8 ng/ml 137.0 20 weeks : upto 64.7 ng/ml 161.75 21 weeks : upto 76.3 ng/ml 190.75 Increased in : Cirrhosis Liver, Chronic Hepatitis, Neural Tube defects, Germ cell Tumours.
|
|
53
|
AFP - Tumour Marker
|
|
Reference Value : 0 to 7.0 ng/ml.
Increased in : Cirrhosis Liver, Chronic Hepatitis, Neural Tube defects, Germ cell Tumours.
|
|
54
|
ALBUMIN
|
0.5 ml
|
Children Upto 4days : 2.8 - 4.4 gm/dl 5 days -14 yrs : 3.8 - 5.4 gm/dl 15 Yrs -18 Yrs : 3.2 - 4.5 gm/dl
Adults : 3.4 - 4.8 gm/dl
|
|
55
|
ALBUMIN (ASCITIC FLUID)
|
|
|
|
56
|
ALCOHOL
|
|
|
|
57
|
ALKALINE PHOSPHATASE
|
0.5 ml
|
Children Male(U/L) Female(U/L) 1 - 30 Days 75- 316 48- 406 30Days-1yr 82- 383 124- 341 1yr-3yrs 104- 345 108- 317 4yrs-6yrs 93- 309 96- 297 7YRS-9YRS 86- 315 69- 325 10YRS-12YRS 42- 362 51- 332 13YRS-15YRS 74- 390 50- 162 16YRS-17YRS 52- 171 47- 119
ADULT MALES : 40-130 U/L ADULT FEMALES : 35-105 U/L
|
|
58
|
ALL SPERM
|
|
>=40
|
|
59
|
ALPHA 1 ANTI TRYPSIN
|
1 ML
|
90 - 200 mg/dl
|
|
60
|
ALTERNARIA ALTERNATA - SPECIFIC IgE
|
1 ml
|
Less than 0.35 IU/mL : Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL : Very High Positive
|
|
61
|
ALUMINIUM
|
|
40 µg/L or less
|
|
62
|
AMA-M2,LKM-1,SLA/LP and LC1.
|
|
SLA/LP., LKM-1,LC-1 and AMA -M2 are done together in a single strip. It is not possible to do any of these tests alone. The charges for a single test or all the tests are the same. Hence all tests will be done and reported.
|
|
63
|
AMINOACIDOGRAM
|
|
|
|
64
|
AMMONIA
|
|
Male : 16 - 60 µmol/L Female : 11 - 51 µmol/L
|
|
65
|
AMPHETAMINE (URINE)
|
|
|
|
66
|
AMYLASE
|
1 ml
|
28-100 U/L
|
|
67
|
AMYLASE (CYSTIC FLUID)
|
|
|
|
68
|
AMYLASE (URINE - 24 HOURS)
|
|
UPTO 1000 IU/L
|
|
69
|
AMYLASE(ASCITIC FLUID)
|
|
|
|
70
|
AMYLASE(PANCREATIC FLUID)
|
|
|
|
71
|
AMYLASE(PLEURAL FLUID)
|
|
|
|
72
|
ANA / ENA EUROLINE
|
1 ml
|
|
|
73
|
ANAEROBIC CULTURE
|
|
|
|
74
|
ANCA
|
1 ml
|
|
|
75
|
ANDROSTENEDIONE
|
1 ml
|
MALES : 0.7 - 3.6 ng/ml
FEMALES : 0.3 - 3.5 ng/ml
|
|
76
|
ANKLE JOINT AP/LAT (LEFT)
|
|
|
|
77
|
ANKLE JOINT AP/LAT (RIGHT)
|
|
|
|
78
|
ANKLE JOINT AP/LAT/OBLIQUE (BOTH)
|
|
|
|
79
|
ANKLE JOINT AP/OBLIQUE (LEFT)
|
|
|
|
80
|
ANKLE JOINT AP/OBLIQUE (RIGHT)
|
|
|
|
81
|
ANTI - RNP
|
|
|
|
82
|
ANTI CCP
|
|
Less than 17.0 U/ml : Negative More than or Equval to 17.0 U/ml : Positive
|
|
83
|
ANTI HB c (TOTAL)
|
1 ml
|
|
|
84
|
ANTI HB c IgM
|
1 ml
|
|
|
85
|
ANTI HBe
|
1 ml
|
|
|
86
|
ANTI HCV
|
1 ml
|
|
|
87
|
ANTI HCV -ECLIA
|
1 ML
|
|
|
88
|
ANTI TB IGA (CSF)
|
|
|
|
89
|
ANTI TB IGG(CSF)
|
|
|
|
90
|
ANTI TB IGG(PLEURAL FLUID)
|
|
|
|
91
|
ANTI TB IGM (CSF)
|
|
|
|
92
|
ANTI TPO ANTIBODIES
|
0.5 ML
|
0.0 - 5.61 IU/ml
|
|
93
|
ANTI CENTROMERE ANTIBODY
|
1 ml
|
|
|
94
|
ANTI GAD ANTIBODIES
|
|
LESS THAN 10 IU/ml : NEGATIVE
MORE THAN OR EQUAL TO 10 IU/mL: POSITIVE
|
|
95
|
Anti GBM Antibodies
|
|
|
|
96
|
ANTI GBM ANTIBODY
|
0.5 ml
|
|
|
97
|
Anti Gliadin Ab IgG
|
|
|
|
98
|
Anti Gliadin IgA
|
|
|
|
99
|
ANTI HAV IgG
|
1 ml
|
Less than 1.0 S/CO : Negative More than 1.0 S/CO : Positive
|
|
100
|
ANTI HAV IgM
|
1 ml
|
|
|
101
|
ANTI HBs (QUANTITATIVE)
|
0.5 ml
|
Less than 10 IU/l : No immunity More than 10 IU/l : Acquired immunity
SUGGESTION FOR REVACCINATION :- Anti HBs Level REVACCINATION After Immunisation TO BE DONE Less than 10 IU/l - Immediately. 10 - 100 IU/l - After 3 - 6 months. 100 - 1000 IU/l - After One year 1000 - 10000 IU/l - After 3 - 5 Years More than 10000 IU/l - After 7 Years.
|
|
102
|
ANTI HEV IgM
|
1 ML
|
|
|
103
|
ANTI LKM 1 ANTIBODIES
|
|
|
|
104
|
ANTI MITOCHONDRIAL ANTIBODY
|
0.5 ml
|
|
|
105
|
ANTI MULLERIAN HORMONE (AMH)
|
|
Age Range
Males 0 - 13d 15.5-48.7 ng/ml 14d- 11m 39.1-91.1 ng/ml 12m- 6y 48.0-83.2 ng/ml 7y - 8y 33.8-60.2 ng/ml Adult 0.6-13.7 ng/ml
Females 0 - 8y 0.0 -0.71 ng/ml Adult 0.19-9.13 ng/ml
|
|
106
|
ANTI NUCLEAR AB ( ANA/ ANF - BY IFA )
|
0.5 ML
|
|
|
107
|
ANTI SMOOTH MUSCLE ANTIBODY
|
1 ml
|
|
|
108
|
ANTI SPERM ANTIBODY
|
0.5 ML
|
Less than 14 U/ml : Negative 14 U/ml 20 U/ml : Equivocal More than 20 U/ml : Positive
|
|
109
|
ANTI TB IGA
|
1 ml
|
Less than 300 U/ml: Negative 300 - 600 U/ml: Low Positive More than 600 U/ml: Positive
|
|
110
|
ANTI TB IGA (ASCITIC FLUID)
|
|
|
|
111
|
ANTI TB IGG
|
1 ml
|
Less than 400 U/ml : Negative 400 - 900 U/ml : Low Positive More than 900 U/ml : Positive
|
|
112
|
ANTI TB IGG (ASCITIC FLUID)
|
|
|
|
113
|
ANTI TB IGM
|
1 ml
|
Less than 0.8 units : Negative 0.8 - 1.0 units : Equivocal More than 1.0 units : Positive
|
|
114
|
ANTI TB IGM (ASCITIC FLUID)
|
|
|
|
115
|
ANTI TSH RECEPTOR ANTIBODY
|
2 Ml
|
Upto 1.22 IU/L
|
|
116
|
ANTITHROMBIN
|
0.5 ML
|
80 - 120 %
|
|
117
|
APC-R ( Activated Protein C Resitance)
|
1 ml
|
Clotting time of More than 120 Seconds reported as Negative , and less than 120 seconds reported as Positive. No time in seconds will be given in the report.
APC-R positive patients may be referred for Factor V Leiden ( FVL) mutation Analysis to find out the Genotype.
|
|
118
|
APO LIPOPROTEIN A1
|
0.5 ml
|
Normal risk Male : 90 - 170 mg/dl Normal risk Female: 107 - 214 mg/dl High Risk : Less than 90 mg/dl Favourable : More than 215mg/dl
|
|
119
|
APO LIPOPROTEIN E
|
|
3 - 6 mg/dl
|
|
120
|
APO LIPOPROTEIN B
|
0.5 ml
|
Normal Risk Male : 56-162 mg/dl Normal Risk Female : 51-171 mg/dl High Risk :More than 171mg/dl Favourable :Less than 51 mg/dl
|
|
121
|
APPENDIX
|
|
|
|
122
|
APTT -Stago
|
|
Reference Range : 27 to 35 Seconds
|
|
123
|
ARSENIC
|
|
|
|
124
|
ASCA
|
1 mL
|
|
|
125
|
ASPERGILLOSIS Ab
|
1 ml
|
Less than 0.35 IU/mL: Negative 0.36 - 0.70 IU/mL : Low Positive 0.71 - 3.50 IU/mL : Moderate Positive 3.51 - 17.50 IU/mL : High Positive More than 17.50 IU/mL: Very High Positive
|
|
126
|
Aspirin Resistance Test
|
|
|
|
127
|
AUDIOMETRY
|
|
|